Clinical Evaluation of Bioactive Injectable Resin Composite in Posterior Restorations

Study Overview
=================
Brief Summary
-----------------
The aim of the study is to evaluate the clinical performance of new bioactive injectable composite compared to nanohybrid composite during the restoration of posterior cavities

Detailed Description
-----------------
Statement of the problem: Marginal defects of composite fillings are often thought to be caused by poor adaptation of the restorative material to the cavity wall. To avoid these defects, particularly in posterior teeth, the use of flowable composites has been advocated because of their ability to 'wet' and adapt well to cavity margins and walls. However, flowable composites have a lower filler content and usually weaker mechanical properties than conventional composites. The continued development of resin composites has led to formulations designed to further simplify the filling procedure, provide better mechanical properties, reduce the effect of polymerization shrinkage stresses and improve aesthetics. Recently, a new type of highly filled flowable composite has been developed. It is characterized by its high viscosity and is claimed to have improved mechanical properties not dissimilar from conventional composite restorative materials. This composite contains nano-sized filler particles, and due to its consistency, the material has been referred to as an 'injectable composite'. Rationale for carrying out the trial: The rationale of this study is to evaluate the mechanical performance of injectable composite resin against nanohybrid composites, because of its easy handling, time-saving, better margin adaptation, and the gain of extra mechanical properties at the same time.

Official Title
-----------------
Clinical Evaluation of Bioactive Injectable Resin Composite Versus Conventional Nanohybrid Composite in Posterior Restorations, 18 m Randomized Controlled Clinical Trial

Conditions
-----------------
Dental Restoration Failure

Intervention / Treatment
-----------------
* Other: Beautifil Flow Plus X F00 injectable composite
* Other: Tetric N ceram resin composite


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Participants: Age range 20-50 years. Males Or females . Co-operative patients approving to participate in the trial. Teeth: class I or II carious lesions premolars and molars. Vital upper or lower teeth with no signs of irreversible pulpitis and pulpal necrosis. Presence of favorable occlusion and teeth are in normal contact with the adjacent teeth. Exclusion Criteria: Participants: Patients with general systemic illness. Allergic history against any component of used material. Disabilities. Pregnancy Xerostomia. Lack of compliance. Evidence of parafunctional habits. Temporomandibular joint disorders. Teeth: Periapical pathology or signs of pulpal pathology. Endodontically treated teeth. Tooth hypersensitivity. Possible prosthodontic restoration of teeth. Heavy occlusion and occlusal contacts or history of bruxism. Severe periodontal affection.

Ages Eligible for Study
-----------------
Minimum Age: 20 Years
Maximum Age: 50 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: injectable composite<br>The material will be applied according to manufacturer instructions. BEAUTIFIL Flow Plus X will be applied directly into the cavity and create the shape desired in layers not exceeding 2 mm, and light cured for 20 seconds. | Other: Beautifil Flow Plus X F00 injectable composite<br>* bioactive injectable composite<br>|
| Active Comparator: Nanohybrid resin composite<br>The nanohybrid resin composite will be applied to the the cavity using the conventional incremental technique according to manufacturer instructions. | Other: Tetric N ceram resin composite<br>* Nano hybrid resin composite<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change in the clinical performance | Measured using modified USPHS criteria | From baseline to 18 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Injectable composite, Nano hybrid composite